Result card

  • CUR15: What kind of variations in the use of intravenous immunoglobulins (IVIG) are there across countries/regions/settings?
English

What kind of variations in the use of intravenous immunoglobulins (IVIG) are there across countries/regions/settings?

Authors: Antonio Migliore, Tapani Keranen, Sinikka Sihvo

Internal reviewers: Kristian Lampe

IVIG are not used for Alzheimer’s disease including Mild Cognitive Impairment in any of the EUnetHTA partners answered the survey. However, while some partners explicitly excluded the use of IVIG for the mentioned indications, some others stated that, given the characteristics of the internal monitoring and reimbursement system, it’s impossible exclude the off-label use of IVIG {Appendix CUR-3}.

Critical
Completely
Migliore A et al. Result Card CUR15 In: Migliore A et al. Health Problem and Current Use of the Technology In: Jefferson T, Cerbo M, Vicari N [eds.]. Use of Intravenous immunoglobulins for Alzeheimer’s disease including Mild Cognitive Impairment [Core HTA], Agenas - Agenzia nazionale per i servizi sanitari regionali ; 2015. [cited 30 October 2020]. Available from: http://corehta.info/ViewCover.aspx?id=267